These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 19409219)

  • 1. Chronic unpredictable stress augments +3,4-methylenedioxymethamphetamine-induced monoamine depletions: the role of corticosterone.
    Johnson BN; Yamamoto BK
    Neuroscience; 2009 Apr; 159(4):1233-43. PubMed ID: 19409219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic stress enhances the corticosterone response and neurotoxicity to +3,4-methylenedioxymethamphetamine (MDMA): the role of ambient temperature.
    Johnson BN; Yamamoto BK
    J Pharmacol Exp Ther; 2010 Oct; 335(1):180-9. PubMed ID: 20634423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges.
    Baumann MH; Clark RD; Franken FH; Rutter JJ; Rothman RB
    Neuroscience; 2008 Mar; 152(3):773-84. PubMed ID: 18313226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered forebrain neurotransmitter responses to immobilization stress following 3,4-methylenedioxymethamphetamine.
    Matuszewich L; Filon ME; Finn DA; Yamamoto BK
    Neuroscience; 2002; 110(1):41-8. PubMed ID: 11882371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3,4-Methylenedioxymethamphetamine administration on postnatal day 11 in rats increases pituitary-adrenal output and reduces striatal and hippocampal serotonin without altering SERT activity.
    Williams MT; Schaefer TL; Ehrman LA; Able JA; Gudelsky GA; Sah R; Vorhees CV
    Brain Res; 2005 Mar; 1039(1-2):97-107. PubMed ID: 15781051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the mechanisms underlying amiloride enhancement of 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats.
    Goñi-Allo B; Puerta E; Hervias I; Di Palma R; Ramos M; Lasheras B; Aguirre N
    Eur J Pharmacol; 2007 May; 562(3):198-207. PubMed ID: 17320075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats.
    Mechan AO; Esteban B; O'Shea E; Elliott JM; Colado MI; Green AR
    Br J Pharmacol; 2002 Jan; 135(1):170-80. PubMed ID: 11786492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic stress augments the long-term and acute effects of methamphetamine.
    Matuszewich L; Yamamoto BK
    Neuroscience; 2004; 124(3):637-46. PubMed ID: 14980734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated exposure to MDMA provides neuroprotection against subsequent MDMA-induced serotonin depletion in brain.
    Bhide NS; Lipton JW; Cunningham JI; Yamamoto BK; Gudelsky GA
    Brain Res; 2009 Aug; 1286():32-41. PubMed ID: 19555677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine.
    Miller DB; O'Callaghan JP
    Mol Neurobiol; 1995; 11(1-3):177-92. PubMed ID: 8561961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protracted effects of chronic stress on serotonin-dependent thermoregulation.
    Natarajan R; Northrop NA; Yamamoto BK
    Stress; 2015; 18(6):668-76. PubMed ID: 26414686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated intermittent methylenedioxymethamphetamine exposure protects against the behavioral and neurotoxic, but not hyperthermic, effects of an MDMA binge in adult rats.
    Piper BJ; Ali SF; Daniels LG; Meyer JS
    Synapse; 2010 Jun; 64(6):421-31. PubMed ID: 20169574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of methamphetamine-induced toxicity in the rat striatum by unpredictable stress: contribution of enhanced hyperthermia.
    Tata DA; Raudensky J; Yamamoto BK
    Eur J Neurosci; 2007 Aug; 26(3):739-48. PubMed ID: 17686046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats.
    O'Shea E; Escobedo I; Orio L; Sanchez V; Navarro M; Green AR; Colado MI
    Neuropsychopharmacology; 2005 Jul; 30(7):1312-23. PubMed ID: 15688085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT.
    Shankaran M; Yamamoto BK; Gudelsky GA
    Synapse; 2001 Apr; 40(1):55-64. PubMed ID: 11170222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin mediates rapid changes of striatal glucose and lactate metabolism after systemic 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") administration in awake rats.
    Gramsbergen JB; Cumming P
    Neurochem Int; 2007 Jul; 51(1):8-15. PubMed ID: 17475367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions.
    Gudelsky GA; Nash JF
    J Neurochem; 1996 Jan; 66(1):243-9. PubMed ID: 8522960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vesicular monoamine transporter 2 and the acute and long-term response to 3,4-(±)-methylenedioxymethamphetamine.
    Lizarraga LE; Cholanians AB; Phan AV; Herndon JM; Lau SS; Monks TJ
    Toxicol Sci; 2015 Jan; 143(1):209-19. PubMed ID: 25370842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent behavioral and neurochemical sensitization to an acute injection of methamphetamine following unpredictable stress.
    Matuszewich L; Carter S; Anderson EM; Friedman RD; McFadden LM
    Behav Brain Res; 2014 Oct; 272():308-13. PubMed ID: 25036423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of acute brain tyrosine depletion on MDMA-induced changes in brain 5-HT.
    Rodsiri R; Green AR; Marsden CA; Fone KC
    J Psychopharmacol; 2010 Feb; 24(2):267-74. PubMed ID: 19965941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.